EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Perinatal outcomes and uptake of RSV vaccine during pregnancy in South London: a cross-sectional study

Mohammad Sharif Razai, Erkan Kalafat, Smriti Prasad, Chelone Lee-Wo, Paul T Heath, Asma Khalil

BMJ Open · 2025

DOI: 10.1136/bmjopen-2025-101592 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift BMJ Open, 2025. Verfasst von Mohammad Sharif Razai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK msr37@cam.ac.uk. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Vaccines, Respiratory Syncytial Virus Infections, Pregnancy Complications, Infectious, Vaccination. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Maternal respiratory syncytial virus (RSV) vaccination has been introduced to protect infants from severe respiratory infections. However, its uptake and impact on perinatal outcomes are unknown in the UK.

Objectives

To evaluate uptake of RSV vaccine during pregnancy in a UK population. Methods and analysis This cross-sectional study was conducted at a tertiary maternity hospital in London. The participants included pregnant women who delivered between 1 September and 17 December 2024 (n=1157). For the analysis of vaccine uptake, the cohort included women eligible for vaccination who delivered beyond 28 weeks’ gestation and were at 36 weeks or less on 1 September 2024 (n=911). The main outcome measures were RSV vaccine uptake and its association with sociodemographic factors, perinatal outcomes including preterm birth (PTB), hypertensive disorders of pregnancy and stillbirth.

Results

Of 911 eligible women, 19% (n=173) received the RSV vaccine during pregnancy. Uptake increased significantly from 4% in September to 32% in December (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus VaccinesRespiratory Syncytial Virus InfectionsPregnancy Complications, InfectiousVaccinationHumansFemalePregnancyCross-Sectional StudiesLondonAdultPregnancy OutcomeYoung AdultInfant, NewbornPremature Birth

Stichwörter der Autor:innen

ImmunologyInfection controlPublic health

Substanzen

Respiratory Syncytial Virus Vaccines

Autor:innen und Institutionen

  • Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK msr37@cam.ac.uk.
  • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Koç Üniversitesi, Istanbul, Türkiye.
  • Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, City St George's, University of London, London, England, UK.
  • Department of Obstetrics and Gynaecology, St George's NHS Trust, London, UK.
  • Vaccine Institute, Institute of Infection and Immunity, City St Georges, University of London, London, UK.
  • Royal College of Obstetricians and Gynaecologists, London, UK.

Zitieren

APA

Razai, M. S., Kalafat, E., Prasad, S., Lee-Wo, C., Heath, P. T., & Khalil, A. (2025). Perinatal outcomes and uptake of RSV vaccine during pregnancy in South London: a cross-sectional study. BMJ Open. https://doi.org/10.1136/bmjopen-2025-101592

Vancouver

Razai MS, Kalafat E, Prasad S, Lee-Wo C, Heath PT, Khalil A. Perinatal outcomes and uptake of RSV vaccine during pregnancy in South London: a cross-sectional study. BMJ Open. 2025. doi:10.1136/bmjopen-2025-101592

BibTeX
@article{Razai2025,
  author = {Razai, Mohammad Sharif and Kalafat, Erkan and Prasad, Smriti and Lee-Wo, Chelone and Heath, Paul T and Khalil, Asma},
  title = {Perinatal outcomes and uptake of RSV vaccine during pregnancy in South London: a cross-sectional study},
  journal = {BMJ Open},
  year = {2025},
  doi = {10.1136/bmjopen-2025-101592}
}
Kostenlos starten →